QNCX logo

Quince Therapeutics, Inc. Common Stock


QNCX: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.


Show QNCX Financials

Consumer Interest
SEC Filings

Recent trades of QNCX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by QNCX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of QNCX in WallStreetBets Daily Discussion


Recent insights relating to QNCX

CNBC Recommendations

Recent picks made for QNCX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in QNCX

Corporate Flights

Flights by private jets registered to QNCX